Trial intelligence / Profile preview

Cefixime and Doxycycline for Gonorrhoea

NCT06090565Phase 4Completed

Sponsor
Bulovka University Hospital
Start
Apr 2021
Primary completion
Jun 2022
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of cefixime, doxycycline in gonorrhea, sponsored by Bulovka University Hospital. Started Apr 2021; status: completed.

02

Drugs

cefiximedoxycycline
03

Conditions

gonorrhea

Beyond the preview

Go deeper on NCT06090565.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06090565.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call